Infervision

Company profile

About Infervision

Infervision Medical Technology Co., Ltd. (推想医疗科技股份有限公司) was established in 2016 with the vision of "improving life and health through AI." The company has positioned itself as an international leader in hospital-wide AI solutions. Infervision employs a comprehensive "horizontal and vertical" strategic approach combined with international expansion. Horizontally, the company covers multiple disease areas including cancer, infectious diseases, cardiovascular disease, cerebrovascular disease, and trauma. Vertically, it follows the patient care pathway from disease screening and diagnosis through intervention and treatment to patient health management and medical research. The company provides advanced integrated smart healthcare services to governments, medical institutions, physicians, and patients. Infervision's products utilize deep learning technology and convolutional neural network models that mimic human cognitive processes. The company's solutions have obtained regulatory clearances from China's NMPA, US FDA, EU CE, UK UKCA, and Japan's PMDA, representing access to five major global markets. Products are deployed in over 1,000 healthcare institutions across more than 30 countries worldwide. The company has accumulated over 390 patents (granted and pending), published more than 350 SCI core papers, and maintains a strong research collaboration network with leading academic medical centers.

Company description · Infervision official website

Mission. AI改善生命健康 (AI to improve life and health)